Aiello, Edoardo Nicolò
Solca, Federica
Torre, Silvia
Carelli, Laura
Ferrucci, Roberta
Priori, Alberto
Verde, Federico
Ticozzi, Nicola
Silani, Vincenzo
Poletti, Barbara http://orcid.org/0000-0003-4398-2051
Article History
Received: 6 August 2022
Accepted: 28 September 2022
First Online: 6 October 2022
Declarations
:
: The participants provided informed consent. This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (I.D.: 2013_06_25).
: V. S. received compensation for consulting services and/or speaking activities from the AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., and Novartis Pharma AG and receives or has received research support from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is on the Editorial Board of the <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i>. B.P. received compensation for consulting services and/or speaking activities from the Liquidweb S.r.l. N. T. received compensation for consulting services from the Amylyx Pharmaceuticals and Zambon Biotech SA. He is an Associate Editor for the <i>Frontiers in Aging Neuroscience</i>. The other authors declare no competing interests.